ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MC2 Therapeutics Announces Positive Top-line Results from EU Phase 3 Head-to-Head Trial Comparing Wynzora? Cream to Daivobet? Gel in Patients with Psoriasis b3cnewswire
December 25, 2019MC2 Therapeutics, an emerging pharmaceutical company focused on novel?PAD? Technology?based topical therapies for chronic inflammatory conditionss, announced that its EU Phase 3 trial (n=490) on the company’s investigational drug ... -
MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora? Cream for Treatment of Plaque Psoriasis b3cnewswire
November 26, 2019MC2 Therapeutics, an emerging pharmaceutical company focused on novel PAD? Technology-based topical therapies for chronic inflammatory conditions ... -
MC2 Therapeutics reports positive Phase III results for experimental psoriasis cream
firstwordpharma
August 22, 2018MC2 Therapeutics?on Tuesday?announced that its investigational psoriasis cream MC2-01 (calcipotriene/betamethasone) demonstrated "significant superiority" in a?Phase III trial?in terms of both treatment...... -
MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis Vulgaris
b3cnewswire
October 13, 2017MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today announced that first patient has been dosed in its pivotal Phase 3 clinical trial assessing the safety and efficacy of?MC2-01 Cream?(calcipotriene and betamethasone
Pharma Sources Insight January 2025
